2 months ago
OLMA
AnalystsRichard LawRichard Law's Stock Forecasts
AnalystsRichard Law
Sectors:
Industries:
Analyst Ranking
Top 10%
#520 out of 5185 analysts
Average Return
+21.64%
Win Rate
34%14 out of 41
Risk vs Reward
Poor
Good
Richard Law's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Olema Pharmaceuticals IncOLMA | +471.56% | $4.50 | $25.72 | 2025-05-13 - 2026-01-30 | Strong Buy |
Olema Pharmaceuticals IncOLMA | +234.19% | $3.89 | $13.00 | 2023-03-09 - 2024-03-08 | Buy |
Olema Pharmaceuticals IncOLMA | +204.17% | $4.56 | $13.87 | 2023-02-21 - 2024-02-21 | Buy |
Mineralys Therapeutics IncMLYS | +202.84% | $10.20 | $30.89 | 2025-02-12 - 2026-01-30 | Strong Buy |
Viridian Therapeutics IncVRDN | +168.51% | $12.29 | $33.00 | 2025-05-06 - 2026-01-30 | Strong Buy |
Richard Law Analyst Color
Get additional color on Richard Law's coverage of popular stocks
2 months ago
OLMA
2 months ago
NUVL
Richard Law's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | 5 | Strong Sell | $10.00 | -36.18% | Downgrades | 18 days ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $28.00 | +33.08% | Upgrades | 20 days ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Strong Buy | $67.00 | +34.16% | Upgrades | 21 days ago |
Olema Pharmaceuticals IncOLMA | 7 | Strong Buy | $38.00 | +47.74% | Maintains | 2 months ago |
Nuvalent IncNUVL | 1 | Strong Buy | $135.00 | +31.21% | Maintains | 2 months ago |
Arcutis Biotherapeutics IncARQT | 2 | Hold | $29.00 | +14.31% | Maintains | 3 months ago |
Mineralys Therapeutics IncMLYS | 7 | Strong Buy | $52.00 | +68.34% | Maintains | 5 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $30.00 | -9.09% | Maintains | 6 months ago |
Silence Therapeutics PLCSLN | 3 | Strong Sell | $3.00 | -37.76% | Maintains | 9 months ago |
Rocket Pharmaceuticals IncRCKT | 3 | Hold | $13.00 | +273.56% | Maintains | 9 months ago |
Celldex Therapeutics IncCLDX | 3 | Hold | $31.00 | +26.02% | Maintains | 9 months ago |
Viking Therapeutics IncVKTX | 1 | Hold | $30.00 | +3.31% | Initiates Coverage On | 10 months ago |
Merus NvMRUS | 1 | Strong Buy | $73.00 | N/A | Initiates Coverage On | a year ago |
Monte Rosa Therapeutics IncGLUE | 4 | Hold | $11.00 | N/A | Reiterates | 2 years ago |
Verve Therapeutics IncVERV | 2 | Hold | $31.00 | N/A | Reiterates | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Hold | $47.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 6 | Hold | $63.00 | N/A | Maintains | 2 years ago |
Kymera Therapeutics IncKYMR | 8 | Hold | $37.00 | N/A | Maintains | 2 years ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $76.00 | N/A | Reiterates | 3 years ago |
Q32 Bio IncQTTB | 4 | Hold | $36.00 | N/A | Reiterates | 3 years ago |
Editas Medicine IncEDIT | 3 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Arvinas IncARVN | 4 | Buy | $61.00 | N/A | Reiterates | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.